Esper Georges Kallas

University of São Paulo (USP) - Hospital das Clinicas HCFMUSP

Brazil

SCHOLARLY PAPERS

6

DOWNLOADS
Rank 2,515

SSRN RANKINGS

Top 2,515

in Total Papers Downloads

19,368

SSRN CITATIONS

0

CROSSREF CITATIONS

5

Scholarly Papers (6)

1.

Efficacy and Safety of a COVID-19 Inactivated Vaccine in Healthcare Professionals in Brazil: The PROFISCOV Study

Number of pages: 66 Posted: 14 Apr 2021
Instituto Butantan, Instituto Butantan, affiliation not provided to SSRN, Instituto Butantan, Instituto Butantan, Instituto Butantan, Instituto Butantan, Institute of Infectious Diseases Emilio Ribas, Federal University of Parana (UFPR), Pontificia Universidade Catolica do Rio Grande do Sul (PUCRS) - School of Medicine, Universidade de Brasília (UnB), Universidade Municipal de São Caetano do Sul (USCS), Hospital Israelita Albert Einstein, Universidade Estadual de Campinas (UNICAMP), University of São Paulo (USP) - Faculdade de Medicina de Ribeirão Preto, Federal University of Pelotas (UFPel), Universidade Federal de Mato Grosso, affiliation not provided to SSRN, Universidade Federal de Mato Grosso do Sul, Oswaldo Cruz Foundation (FIOCRUZ) - Evandro Chagas National Institute of Infectious Diseases (INI), University of São Paulo (USP), Instituto Butantan, Sinovac Biotech CO., Ltd., Sinovac Life Sciences Co., Ltd., Federal University of Minas Gerais (UFMG), Faculdade de Medicina de São José de Rio Preto (FAMERP) and University of São Paulo (USP) - Hospital das Clinicas HCFMUSP
Downloads 19,120 (213)
Citation 55

Abstract:

Loading...

Brazil, COVID-19, COVID-19 Vaccine, Inactivated Vaccines, Phase III Clinical Trial, Randomised controlled trial, protocol

2.

Safety and Immunogenicity of CoronaVac in People Living with HIV

Number of pages: 21 Posted: 22 Sep 2021
Laboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Department of Infectious and Parasitic Diseases, Laboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Department of Infectious and Parasitic Diseases, Laboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Department of Infectious and Parasitic Diseases, Laboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Department of Infectious and Parasitic Diseases, Laboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Department of Infectious and Parasitic Diseases, Laboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Department of Infectious and Parasitic Diseases, Laboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Department of Infectious and Parasitic Diseases, Laboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Rheumatology DivisionLaboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Rheumatology Division, Laboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Rheumatology Division, Laboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Rheumatology Division, Laboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Rheumatology Division, Laboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Rheumatology Division, Laboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Rheumatology Division, Laboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Department of Infectious and Parasitic Diseases, Laboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Department of Pathology, Laboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Rheumatology Division, University of São Paulo (USP) - Hospital das Clinicas HCFMUSP and Hospital Israelita Albert Einstein - School of Medicine
Downloads 113 (330,498)

Abstract:

Loading...

SARS-CoV-2, COVID-19, vaccine, HIV, immunogenicity, neutralizing antibodies, CoronaVac

3.

Clinical Characteristics of COVID-19 by SARS-CoV-2 Gamma Variant in Vaccinated and Non-Vaccinated Healthcare Workers

Number of pages: 19 Posted: 11 Aug 2021
University of São Paulo (USP) - LIM-46 e LIM-49 do Instituto de Medicina Tropical, University of São Paulo (USP) - LIM-46 e LIM-49 do Instituto de Medicina Tropical, University of São Paulo (USP) - Hospital das Clinicas HCFMUSP, University of São Paulo (USP) - Centro de atendimento ao colaborador, University of São Paulo (USP) - Centro de atendimento ao colaborador, University of São Paulo (USP) - Centro de atendimento ao colaborador, University of São Paulo (USP) - Hospital das Clinicas HCFMUSP, University of São Paulo (USP) - LIM-46 e LIM-49 do Instituto de Medicina Tropical, University of São Paulo (USP) - Hospital das Clinicas HCFMUSP, University of São Paulo (USP) - Hospital das Clinicas HCFMUSP, University of São Paulo (USP) - Divisão do Laboratório Central, University of São Paulo (USP) - Divisão de Laboratório Central, University of São Paulo (USP) - Department of Epidemiology, University of São Paulo (USP) - LIM-46 e LIM-49 do Instituto de Medicina Tropical, University of São Paulo (USP) - LIM-46 e LIM-49 do Instituto de Medicina Tropical, University of São Paulo (USP) - LIM-46 e LIM-49 do Instituto de Medicina Tropical, University of São Paulo (USP) - Hospital das Clinicas HCFMUSP and University of São Paulo (USP) - LIM-46 e LIM-49 do Instituto de Medicina Tropical
Downloads 51 (514,906)

Abstract:

Loading...

4.

Dynamics of Inactivated SARS-CoV-2 Vaccine Antibody Response in SARS-CoV-2-Seropositive Autoimmune Rheumatic Disease Patients

Number of pages: 31 Posted: 29 Jul 2021
Laboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Rheumatology DivisionLaboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Rheumatology Division, Laboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Rheumatology Division, Laboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Rheumatology Division, Laboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Rheumatology Division, Laboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Rheumatology Division, Laboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Rheumatology Division, Laboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Rheumatology Division, Laboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Rheumatology Division, University of São Paulo (USP) - Faculty of Medicine, Laboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Rheumatology Division, Laboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Rheumatology Division, Laboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Rheumatology Division, Laboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Rheumatology Division, Laboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Rheumatology Division, Laboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Rheumatology Division, Laboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Rheumatology Division, University of São Paulo (USP) - Divisão do Laboratório Central, Laboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Rheumatology Division, University of São Paulo (USP) - LIM-46 e LIM-49 do Instituto de Medicina Tropical, Laboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Rheumatology Division, University of São Paulo (USP) - Hospital das Clinicas HCFMUSP, Laboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Rheumatology Division and Laboratorio de Biologia Celular, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo - Rheumatology Division
Downloads 51 (514,906)

Abstract:

Loading...

autoimmune rheumatic diseases, COVID-19, vaccine, seropositive, immunogenicity

5.

Efficacy and Safety of Ixekizumab vs. Low-Dose IL-2 vs. Colchicine vs. Standard of Care on the Treatment of Patients Hospitalized with Moderate to Critical Covid-19: A Pilot Randomized Clinical Trial (STRUCK: Survival Trial Using Cyto kine Inhibitors)

Number of pages: 17 Posted: 28 Apr 2022
University of São Paulo (USP) - Ribeirão Preto Medical School, Science Valley Research Institute, Science Valley Research InstituteScience Valley Research Institute, University of São Paulo (USP) - Ribeirão Preto Medical School, University of São Paulo (USP) - Ribeirão Preto Medical School, University of São Paulo (USP) - Ribeirão Preto Medical School, University of São Paulo (USP) - Ribeirão Preto Medical School, University of São Paulo (USP) - Ribeirão Preto Medical School, Science Valley Research Institute, Science Valley Research Institute, Hospital e Maternidade Christóvão da Gama, Hospital do Rocio, Hospital do Rocio, Hospital do Rocio, Hospital do Rocio, Irmandade Santa Casa de Misericórdia de Porto Alegre, Irmandade Santa Casa de Misericórdia de Porto Alegre, Brazilian Clinical Research Institute, University of São Paulo (USP) - Hospital das Clinicas HCFMUSP and University of São Paulo (USP) - Ribeirão Preto Medical School
Downloads 30 (623,201)

Abstract:

Loading...

Covid-19, SARS-CoV-2, Cytokine storm, Ixekizumab, Interleukin-2, Colchicine

6.

Immune Metabolic Interplay Drives the Protective Antibody Response Pre-Vaccination with Dengue Virus Vaccine

Number of pages: 120 Posted: 18 May 2022
RPM Bioinfo Solutions, Emory University - Pathology Advanced Translational Research Unit, Drexel University - Department of Medicine and Microbiology and Immunology, CellCarta, Hospital Israelita Albert Einstein, Case Western Reserve University - Department of Pathology, Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), CellCarta, University of São Paulo (USP) - Clinical Immunology and Allergy Division, Instituto Adolfo Lutz, Butantan Institute, Washington University School of Medicine - Department of Medicine, Drexel University - Department of Medicine and Microbiology and Immunology, University of São Paulo (USP) - Hospital das Clinicas HCFMUSP and Emory University - Pathology Advanced Translational Research Unit
Downloads 3 (848,554)

Abstract:

Loading...